These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34471711)

  • 21. Newborn screening and diagnosis of mucopolysaccharidoses.
    Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses.
    Hochuli M; Wüthrich K; Steinmann B
    NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).
    Tomatsu S; Alméciga-Díaz CJ; Barbosa H; Montaño AM; Barrera LA; Shimada T; Yasuda E; Mackenzie WG; Mason RW; Suzuki Y; Orii KE; Orii T
    Expert Opin Orphan Drugs; 2013 Oct; 1(10):805-818. PubMed ID: 25419501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions.
    Wolfberg J; Chintalapati K; Tomatsu S; Nagao K
    Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32759694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme replacement therapy for mucopolysaccharidoses; past, present, and future.
    Chen HH; Sawamoto K; Mason RW; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Tomatsu S
    J Hum Genet; 2019 Nov; 64(11):1153-1171. PubMed ID: 31455839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.
    Tomatsu S; Montaño AM; Oikawa H; Smith M; Barrera L; Chinen Y; Thacker MM; Mackenzie WG; Suzuki Y; Orii T
    Curr Pharm Biotechnol; 2011 Jun; 12(6):931-45. PubMed ID: 21506915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spondyloepiphyseal dysplasias and bilateral legg-calvé-perthes disease: diagnostic considerations for mucopolysaccharidoses.
    Mendelsohn NJ; Wood T; Olson RA; Temme R; Hale S; Zhang H; Read L; White KK
    JIMD Rep; 2013; 11():125-32. PubMed ID: 23657977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme replacement therapy: efficacy and limitations.
    Concolino D; Deodato F; Parini R
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):120. PubMed ID: 30442189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II.
    Higuchi T; Shimizu H; Fukuda T; Kawagoe S; Matsumoto J; Shimada Y; Kobayashi H; Ida H; Ohashi T; Morimoto H; Hirato T; Nishino K; Eto Y
    Mol Genet Metab; 2012 Sep; 107(1-2):122-8. PubMed ID: 22704483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updated Confirmatory Diagnosis for Mucopolysaccharidoses in Taiwanese Infants and the Application of Gene Variants.
    Chuang CK; Tu YR; Lee CL; Lo YT; Chang YH; Liu MY; Liu HY; Chen HJ; Kao SM; Wang LY; Ho HJ; Lin HY; Lin SP
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular Abnormalities in Egyptian Children with Mucopolysaccharidoses.
    Selim L; Abdelhamid N; Salama E; Elbadawy A; Gamaleldin I; Abdelmoneim M; Selim A
    J Clin Diagn Res; 2016 Nov; 10(11):SC05-SC08. PubMed ID: 28050459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI.
    Lin HY; Chuang CK; Chen MR; Lin SM; Hung CL; Chang CY; Chiu PC; Tsai WH; Niu DM; Tsai FJ; Lin SJ; Hwu WL; Lin JL; Lin SP
    Mol Genet Metab; 2016 Apr; 117(4):431-7. PubMed ID: 26899310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical and molecular analysis of mucopolysaccharidoses in Turkey.
    Emre S; Terzioğlu M; Coşkun T; Tokath A; Ozalp I; Müller V; Hopwood J
    Turk J Pediatr; 2002; 44(1):13-7. PubMed ID: 11858372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
    Sawamoto K; Álvarez González JV; Piechnik M; Otero FJ; Couce ML; Suzuki Y; Tomatsu S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional capacity evaluation of patients with mucopolysaccharidosis.
    Guarany NR; Schwartz IV; Guarany FC; Giugliani R
    J Pediatr Rehabil Med; 2012; 5(1):37-46. PubMed ID: 22543891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
    Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
    Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical diagnosis of Sanfilippo disorder types A and B.
    Nosier SS; El Nakeeb SMS; Ibrahim MM; El-Gammal M; Fateen EM
    J Genet Eng Biotechnol; 2023 Nov; 21(1):112. PubMed ID: 37947910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy.
    Poswar FO; de Souza CFM; Giugliani R; Baldo G
    Heart Vessels; 2019 Feb; 34(2):290-295. PubMed ID: 30136169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory process and oxidative/nitrative stress: in vivo study in mucopolysaccharidosis type IV A patients under long-term enzyme replacement therapy.
    Aguilar Delgado C; Hammerschmidt T; Faverzini JL; Lopes F; Giugliani R; Baldo G; Vargas CR
    Arch Biochem Biophys; 2023 Mar; 737():109541. PubMed ID: 36754222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy.
    Maccari F; Rigon L; Mantovani V; Galeotti F; Salvalaio M; D'Avanzo F; Zanetti A; Capitani F; Gabrielli O; Tomanin R; Volpi N
    J Mol Med (Berl); 2022 Aug; 100(8):1169-1179. PubMed ID: 35816218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.